Results 31 to 40 of about 137,565 (249)

Pleural cytokines MIF and MIP-3α as novel biomarkers for complicated parapneumonic effusions and empyema

open access: yesScientific Reports, 2021
Patients with complicated parapneumonic effusion (CPPE)/empyema have high morbidity and mortality, particularly when adequate management is delayed.
Chia-Yu Yang   +10 more
doaj   +1 more source

Dose de-escalation of intrapleural tissue plasminogen activator therapy for pleural infection. The alteplase dose assessment for Pleural infection Therapy project [PDF]

open access: yes, 2017
Rationale: Intrapleural therapy with a combination of tissue plasminogen activator (tPA) 10 mg and DNase 5 mg administered twice daily has been shown in randomized and open-label studies to successfully manage over 90% of patients with pleural infection ...
Bintcliffe, Oliver   +10 more
core   +1 more source

Experimental pleural empyema model in rabbits: Why, how and what are the next steps [PDF]

open access: yes, 2014
Bacgraund/Aim. The use of new therapeutic methods to prevent development of fibrothorax as the final complication of the human pleural infections requires research with experimental animals.
Cvijanović Vlado   +6 more
core   +1 more source

Clinical and etiological profile of an exudative pleural effusion in a tertiary care center

open access: yesIndian Journal of Respiratory Care, 2019
Background: Pleural effusion is common clinical entity in day-to-day clinical practice. There are various etiologies for pleural effusion. Among those tubercular pleural effusion, parapneumonic effusion, malignant effusion, and congestive heart failure ...
S Laxma Reddy   +5 more
doaj   +1 more source

The modern diagnosis and management of pleural effusions [PDF]

open access: yes, 2015
A pleural effusion describes an excess of fluid in the pleural cavity, usually resulting from an imbalance in the normal rate of pleural fluid production or absorption, or both.
Bhatnagar, Rahul, Maskell, Nick A
core   +2 more sources

The usefulness of pleural fluid presepsin, C-reactive protein, and procalcitonin in distinguishing different causes of pleural effusions

open access: yesBMC Pulmonary Medicine, 2018
Background We aimed to determine the presepsin concentration in pleural fluid from patients with pleural effusions of different aetiologies and to compare its diagnostic value with that of pleural fluid C-reactive protein (CRP) and procalcitonin (PCT ...
Naoki Watanabe   +9 more
doaj   +1 more source

Analysis of clinical characteristics and risk factors of community-acquired pneumonia complicated by parapneumonic pleural effusion in elderly patients

open access: yesBMC Pulmonary Medicine, 2023
Background Community-acquired pneumonia (CAP) patients usually present with parapneumonic pleural effusion (PPE), which complicates the treatment of pneumonia.
Mingmei Zhong   +3 more
semanticscholar   +1 more source

A clinical study of pleural effusion and its radiological, biochemical, bacteriological and cytological correlation

open access: yesJournal of Integrated Health Sciences, 2017
Introduction: Pleural effusion refers to excessive or abnormal accumulation of fluid in the pleural space. It is a commonly encountered medical problem caused by a variety of underlying pathological conditions.
N D Khamar   +3 more
doaj   +1 more source

Primary Effusion Lymphoma Presenting As Parapneumonic Pleural Effusion

open access: yesCureus, 2022
Primary effusion lymphoma (PEL) is a rare form of high-grade non-Hodgkin's lymphoma that usually occurs in patients with compromised immunity or human immunodeficiency virus (HIV) infection. PEL is a B-cell lymphoma that principally presents as effusions without a tumor mass.
Gujarathi, Rahul   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy